The estimated Net Worth of Erin Jones is at least $724 Thousand dollars as of 15 May 2024. Mr Jones owns over 13,749 units of Gritstone Bio Inc stock worth over $176,054 and over the last 6 years he sold GRTS stock worth over $10,312. In addition, he makes $537,384 as Chief Operating Officer at Gritstone Bio Inc.
Mr has made over 7 trades of the Gritstone Bio Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 13,749 units of GRTS stock worth $10,312 on 15 May 2024.
The largest trade he's ever made was selling 13,749 units of Gritstone Bio Inc stock on 15 May 2024 worth over $10,312. On average, Mr trades about 2,839 units every 138 days since 2019. As of 15 May 2024 he still owns at least 359,293 units of Gritstone Bio Inc stock.
You can see the complete history of Mr Jones stock trades at the bottom of the page.
Erin E. Jones M.S. is the Chief Operating Officer at Gritstone Bio Inc.
As the Chief Operating Officer of Gritstone Bio Inc, the total compensation of Mr S at Gritstone Bio Inc is $537,384. There are 6 executives at Gritstone Bio Inc getting paid more, with Andrew Allen having the highest compensation of $2,187,440.
Mr S is 49, he's been the Chief Operating Officer of Gritstone Bio Inc since . There are 12 older and 7 younger executives at Gritstone Bio Inc. The oldest executive at Gritstone Bio Inc is Alan C. Mendelson J.D., 71, who is the Sec..
Erin's mailing address filed with the SEC is C/O GRITSTONE BIO, INC., 5959 HORTON STREET, SUITE 300, EMERYVILLE, CA, 94608.
Over the last 6 years, insiders at Gritstone Bio Inc have traded over $277,077 worth of Gritstone Bio Inc stock and bought 2,026,375 units worth $15,022,790 . The most active insiders traders include Group, Llc Green Jeremy Red..., Peter Svennilson, and Thomas Woiwode. On average, Gritstone Bio Inc executives and independent directors trade stock every 103 days with the average trade being worth of $54,654. The most recent stock trade was executed by Andrew R Allen on 15 May 2024, trading 24,263 units of GRTS stock currently worth $18,197.
gritstone oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and very deep financial backing to tackle fundamental challenges at the intersection of cancer biology, immunology, and immunotherapy design. the company’s initial goal is to identify and deploy therapeutic neo-antigens from individual patients’ tumors to develop novel treatments for lung cancer. gritstone oncology is headquartered in the san francisco bay area with certain key functions located in cambridge, ma. gritstone oncology launched in october 2015 with a series a financing of $102 million.
Gritstone Bio Inc executives and other stock owners filed with the SEC include: